SpaceX is considered the leader in space-based connectivity and is significantly ahead of Amazon in terms of the number of satellites in orbit.

Amazon's low earth orbit (LEO) satellite network is not yet in use.

Eli Lilly's acquisition of Sentosa reflects a strategic bet that the market for sleep disorder treatments will become a multi-billion dollar industry.

The acquisition of Globalstar will accelerate Amazon's plans to become a formidable competitor to Starlink in the space-based connectivity market.

The terms of the Amazon-Globalstar deal include a 40% cap on the amount of cash that shareholders can elect to receive.

Amazon plans to enter the direct-to-device satellite market in 2028.

Through its acquisition of Globalstar, Amazon will gain ground infrastructure and a major customer relationship with Apple.

The CEO of Globalstar is Paul Jacobs, who was formerly the CEO of Qualcomm.

SpaceX considered acquiring Globalstar last year before Amazon prevailed with its offer.

Biogen's acquisition of two drugs from Apellis Pharmaceuticals provides immediate revenue, as the drugs generated approximately $700 million for Apellis in the previous year.

Under CEO Chris Viehbacher, Biogen is seeking to diversify into new disease areas to find new revenue sources as its multiple sclerosis franchise ages.

The $11.6 billion acquisition of Globalstar is Amazon's largest deal since its purchase of Whole Foods in 2017.

Amazon aims to launch a direct-to-device satellite service by 2028, providing voice, text, and data connectivity without cell towers.

Amazon's acquisition of Globalstar is primarily motivated by the need to acquire valuable and scarce spectrum for its satellite operations.

As part of the acquisition deal, Amazon negotiated to retain Apple as a customer for Globalstar's satellite-based emergency services.